| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
MAGDEBURG, Germany—Methods designed to analyze a proteome often start by taking proteins out of their cellular context. Fluorescence microscopy alleviates this problem to some extent, but recently researchers at Otto-von-Guericke-University Magdeburg, MelTec GmbH and other institutes took this method one step further, determining the cellular topology of a proteome using multi-epitope-ligand cartography (MELC).
 
As they described in Nature Biotechnology, MELC works by building a composite fluorescent image of tissues that are treated with cycles of probing and bleaching with labeled antibodies. Using MELC, the researchers mapped 18 cell-surface receptors in peripheral blood cells, reducing each binding event a vector of fluorescence intensity. They thus generated combinatorial molecular phenotypes (CMPs) based on a binary code of 1 (presence), 0 (absence) or * (wild-card).
 
By comparing CMPs of diseased and healthy tissues, the researchers noted that whereas overall proteomes may not differ between the two cell types, the CMPs differed significantly. The method also allowed them to elucidate protein networks and identify hub proteins for many of these networks, many of which were not previously identified. As such, they see the method as providing a tool to identify candidate target proteins in disease.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue